"Nanobrid Innovations" is privately held company offering proprietary next generation lipid-polymer hybrid nanotechnology platform for applications in pharmaceutical, cosmetics, and nutraceuticals

Mission

Our mission is to establish us as a trusted expert in nanotechnology-based reformulation.

Vision

Our vision is to redefine clinical outcomes and patient experience through next generation formulation science.

Our team

Dr. Deepak Chitkara (co-founder)

Deepak is a formulation scientist trained in India and USA and currently Assistant Professor at the Department of Pharmacy, Birla institute of Technology and Science (BITS). Deepak holds a Ph D. and specialized in development of nanotechnology-based drug delivery platforms. Deepak is focusing on advancing research programs across range of molecules / drug delivery platforms and scaling-up R&D capabilities.

Nemisha Patel (co-founder)

An astute pharmaceutical professional with 22 plus years of exceptional expertise in the pharmaceutical/ medical device industries. Nemisha has 17 years of experiences in development of pre-clinical platforms of novel vaccines, biologics and diagnostics at Merck Pharmaceuticals and B.Braun Medical Inc. Nemisha is a respected professional in the industry, recommended by the industry for consultation on areas of Regulatory Compliance and Quality Assurance. Nemisha holds a M.S. in Microbiology from Thomas Jefferson University and B.S. in Biology from Temple University.

Mayank (CO-FOUNDER)

Mayank has 13+ years of experience in multi-national consulting and pharmaceutical companies. Mayank has expertise in the areas of health economics and outcome research, medical affairs, operations, developing strategy and managing innovation. Mayank holds Masters in Pharmacy from National Institute of Pharmaceutical Education & Research (NIPER), Chandigarh, India and completed Advance Management Program from Indian Institute of Management (IIM), Bangalore, India.

Dr. Anupama Mittal (CO-FOUNDER)

Anupama holds a Ph.D. degree in pharmaceutical sciences from India and did her post-doctoral training in the United States before joining as a faculty at the Department of Pharmacy, Birla Institute of Technology and Science-Pilani (BITS-Pilani). She specializes in the development of new formulations for difficult to deliver molecules using nanotechnology-based approaches.

Our extended team

We are proud of broad network of specialists in the areas of formulation science, intellectual property rights, regulatory affairs, pharmaceutical industry veterans, and researching clinicians.